Data / Drug companies / Moxifloxacin hydrochloride
Moxifloxacin hydrochloride: 20 companies and 26 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Moxifloxacin hydrochloride is listed in the FDA National Drug Code Directory by 20 companies, with 26 products in commercial distribution. 22 of the products (84.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; solution/ drops; injection, solution, and the newest product started marketing on December 12, 2025.
The request: Get every company that lists moxifloxacin hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 20
- Products
- 26
- Generic (ANDA) products
- 22 (84.6%)
- Application numbers
- 7
- Routes
- Oral, Ophthalmic, Intravenous
- Brand names
- Moxifloxacin, Moxifloxacin Ophthalmic Solution, Vigamox
- openFDA record search
- api.fda.gov
Companies that list moxifloxacin hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 3 | tablet, film coated | Generic drugs (ANDA) | March 4, 2014 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | March 4, 2014 |
| Bryant Ranch Prepack | 2 | tablet, film coated | Generic drugs (ANDA) | March 4, 2014 |
| Remedyrepack Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | August 27, 2025 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | March 19, 2014 |
| Asclemed USA, Inc. | 1 | solution | Generic drugs (ANDA) | February 10, 2021 |
| Aurobindo Pharma Limited | 1 | tablet, film coated | Generic drugs (ANDA) | March 4, 2014 |
| AvPAK | 1 | tablet, film coated | Generic drugs (ANDA) | July 22, 2016 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | New drug applications (NDA) | March 18, 2015 |
| Harrow Eye, LLC | 1 | solution/ drops | New drug applications (NDA) | July 1, 2024 |
| Hp Halden Pharma As | 1 | injection, solution | New drug applications (NDA) | August 2, 2017 |
| Kesin Pharma Corporation | 1 | tablet, film coated | Generic drugs (ANDA) | December 12, 2025 |
| Major Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | March 8, 2024 |
| Mylan Institutional LLC | 1 | injection, solution | Generic drugs (ANDA) | October 3, 2017 |
| Redpharm Drug | 1 | solution/ drops | Generic drugs (ANDA) | November 25, 2024 |
| Rising Pharma Holdings, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | March 4, 2014 |
| Sandoz Inc | 1 | solution/ drops | Authorized generics (NDA) | May 7, 2003 |
| Solaris Pharma Corporation | 1 | tablet, film coated | Generic drugs (ANDA) | December 12, 2025 |
| Somerset Therapeutics, LLC | 1 | solution/ drops | Generic drugs (ANDA) | November 25, 2024 |
| Upsher-Smith Laboratories, LLC | 1 | solution | Generic drugs (ANDA) | February 10, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 17 | 65.4% |
| Solution/ drops | 4 | 15.4% |
| Injection, solution | 3 | 11.5% |
| Solution | 2 | 7.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 22 | 84.6% |
| New drug applications (NDA) | 3 | 11.5% |
| Authorized generics (NDA) | 1 | 3.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Fluoroquinolone Antibacterial | 25 |
| Quinolone Antimicrobial | 1 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.